Research programme: colostrinin constituent peptides - ReGen Therapeutics
Alternative Names: ColostininLatest Information Update: 16 Jul 2016
At a glance
- Originator Nonindustrial source
- Class Peptides
- Mechanism of Action Amyloid beta-protein inhibitors; Antioxidants; Apoptosis inhibitors; Cell differentiation stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Alzheimer's disease; Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in United Kingdom (PO)
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in United Kingdom
- 01 Sep 2006 Early research in Cancer in United Kingdom (unspecified route)